New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|June 1, 1996
Supplements and Featured Publications
- Managing the Patient at Risk for NSAID Toxicity Consensus Conference
- Volume 2
- Issue 8 Suppl
GI Toxicity of NSAIDs: Incidence, Complications, Management Strategy
Author(s)Denis M. McCarthy, MD, MSc
Advertisement
Articles in this issue
over 30 years ago
Participantsover 30 years ago
Goals and Long-Term Management of Arthritis with NSAIDsover 30 years ago
Defining the Patient at Risk for NSAID ToxicityAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement